Hematology and Oncology
Home Hematology and Oncology
Second, Unrelated Malignancies Strike 1 in 12 Cancer Patients
Second cancer was fatal in 55 percent of the cases studied
Medical Marijuana Laws Affect Medicare Part D Spending
Implementation of medical marijuana laws linked to reductions in Medicare program, enrollee spending
CDC: Majority of HPV-Linked Cancers Are Preventable
Cervical cancer, and oropharyngeal cancers in men, account for most HPV-associated cancers
Circulating Tumor DNA May Help Predict Colon CA Recurrence
Findings in patients after resection of stage II colon cancer
VA Appealing to Physicians to Join Agency
Key efforts in response to 2014 scandal include reducing wait times, engaging employees
Nonsolid Nodules Unlikely to Cause Death in Lung Cancer
Lung cancers that manifest as nonsolid nodules seem to have indolent course
DNA-Repair Gene Mutations ID’d in Metastatic Prostate Cancer
Prevalence of 11.8 percent for germline DNA-repair gene mutations presumed to be deleterious
Neratinib Active in HER2-Positive, HR-Negative Breast Cancer
And higher pathologic complete response for veliparib-carboplatin in triple-negative breast cancer
Docs Tending Away From Post-Prostatectomy Adjuvant RT
Urologists in Australia less favorable toward adjuvant radiotherapy in 2015 versus 2012
Many Clinical Trials Are Not Listed in Data-Sharing Repository
Fifty-three percent of randomized clinical trials were listed at Clinical Study Data Request website
